Published in World J Gastroenterol on September 21, 2009
Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol (2013) 1.85
Gastric Cancer and Paraneoplastic Pemphigus. Indian J Surg (2015) 0.75
Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med (1949) 8.32
Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40
Acanthosis nigricans. J Am Acad Dermatol (1994) 4.11
Genetic predisposition to colorectal cancer. Nat Rev Cancer (2004) 3.92
Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med (1955) 3.70
Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med (1992) 3.56
The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol (1995) 2.70
Hypertrichosis. J Am Acad Dermatol (2003) 2.54
Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med (1990) 2.49
Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg (1967) 2.30
Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med (2001) 2.19
Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion (2004) 2.19
Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol (1993) 1.86
Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med (1991) 1.82
A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene (2007) 1.82
Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol (2001) 1.79
Dermatomyositis. J Am Acad Dermatol (1998) 1.79
Multiple sebaceous tumors. Arch Dermatol (1968) 1.79
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer (2001) 1.72
Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med (1987) 1.66
Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol (2004) 1.62
The sign of Leser-Trélat: does it exist? J Am Acad Dermatol (1989) 1.57
Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) (1968) 1.50
Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) (1991) 1.49
Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol (2001) 1.46
Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol (2004) 1.35
Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol (2002) 1.33
Skin involvement in dermatomyositis. Curr Opin Rheumatol (2003) 1.31
Malignancy in adult dermatomyositis. Int J Dermatol (1997) 1.20
Muir-Torre syndrome. Dermatol Clin (1995) 1.17
Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol (2000) 1.13
Cronkhite-Canada syndrome. Digestion (2005) 1.12
Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol (1997) 1.10
Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol (1990) 1.08
Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol (2007) 1.07
Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (2000) 1.06
Malignant acanthosis nigricans: potential role of chemotherapy. Br J Dermatol (1999) 1.05
Paraneoplastic pemphigus. J Investig Dermatol Symp Proc (2004) 1.04
Bazex syndrome: acrokeratosis paraneoplastica. Semin Dermatol (1995) 1.01
On the classification of the sign of Leser-Trélat. J Am Acad Dermatol (1988) 0.88
Acrokeratosis paraneoplastica (Bazex syndrome) with adenocarcinoma of the colon: report of a case and review of the literature. J Gastroenterol (2000) 0.87
Cronkhite-Canada syndrome: report of two cases, biopsy findings in the associated alopecia, and a new treatment option. Cutis (1998) 0.86
"Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. J Invest Dermatol (2001) 0.86
Dermatomyositis: cutaneous manifestations of its variants. Int J Dermatol (2002) 0.85
Acanthosis palmaris: tripe palms. A distinctive pattern of palmar keratoderma frequently associated with internal malignancy. Clin Exp Dermatol (1980) 0.83
Dermatomyositis and malignancy: case report and review of the Japanese literature. Tumori (1996) 0.82
A Muir-Torre syndrome family. Am Surg (1998) 0.82
Generalized gastrointestinal polyposis. An unusual syndrome of adenomatous polyposis, alopecia, onychorotrophia. Am J Gastroenterol (1967) 0.81
Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination. Br J Dermatol (2007) 0.81
Skin manifestations in visceral cancer. Curr Probl Dermatol (1978) 0.80
Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked? Br J Dermatol (2007) 0.80
Dermatomyositis associated with malignancy. 12 case reports. Adv Exp Med Biol (1999) 0.80
A case of hepatocellular carcinoma with the sign of Leser-Trelat: a possible role of a cutaneous marker for internal malignancy. Jpn J Med (1991) 0.78
The sign of Leser-Trélat associated with adenocarcinoma of the rectum. Cutis (1993) 0.78
Linear seborrheic keratoses associated with underlying malignancy. J Am Acad Dermatol (1988) 0.77
Sebaceous carcinomas of the ocular adnexa and the Muir-Torre syndrome. J Am Acad Dermatol (1992) 0.77
[Palmar and plantar hyperkeratosis associated with a gastric adenocarcinoma]. Dermatologica (1982) 0.77
[Leser-Trélat sign in adenocarcinoma of the sigmoid colon--a rare clinical picture]. Z Hautkr (1987) 0.76
Leser Trelat sign associated with carcinoma of gastro-oesophageal junction. Indian J Cancer (1983) 0.76
Generalized acanthosis nigricans. Dermatologica (1981) 0.76
Acanthosis nigricans and wart-like lesions associated with metastatic carcinoma of the stomach. Cutis (1976) 0.76
Paraneoplastic pemphigus without an underlying neoplasm. Br J Dermatol (2007) 0.76
Post-renal transplantation Leser-Trélat sign associated with carcinoma of the gallbladder: a rare association. Scand J Gastroenterol (2007) 0.76
Seborrhoeic keratoses and carcinoma of the large bowel. Three cases exhibiting the sign of Lester-trélat. Br J Dermatol (1975) 0.76
Peutz-Jeghers syndrome with prominent palmoplantar pigmentation. Indian J Dermatol Venereol Leprol (2008) 0.76
Pancreatic carcinoma associated with the Leser-Trélat sign. Int J Pancreatol (1997) 0.76
[Hypertrichosis lanuginosa acquisita in ulcerative colitis with colon cancer]. Hautarzt (1992) 0.76
Acrokeratosis paraneoplastica (Bazex syndrome) with oropharyngeal squamous cell carcinoma. Cutis (1995) 0.76
Sign of Leser-Trélat associated with adenocarcinoma of the rectum. Eur J Dermatol (2001) 0.76
The leser-trelat sign in association with carcinoma of the ampulla of Vater. Am J Gastroenterol (2001) 0.76
Sign of Leser-Trélat with a metastatic mucinous adenocarcinoma. Cutis (1991) 0.76
Paraneoplastic pemphigus in the absence of a known neoplasm. J Am Acad Dermatol (1995) 0.76
[Gastrointestinal carcinoma with skin diseases from the standpoint of surgery]. Gan To Kagaku Ryoho (1988) 0.76
The sign of Leser-Trélat associated with carcinoma of the stomach. Am J Gastroenterol (1988) 0.76
Pancreatic pseudocyst. World J Gastroenterol (2009) 1.96
Endoscopic therapy of benign biliary strictures. World J Gastroenterol (2007) 1.53
Fully covered Alimaxx esophageal metal stents in the endoscopic treatment of benign esophageal diseases. Dig Dis Sci (2010) 1.49
Squamous cell cancer of the rectum. World J Gastroenterol (2009) 1.43
Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol (2009) 1.36
Prospective evaluation of the use of fully covered self-expanding metal stents for EUS-guided transmural drainage of pancreatic pseudocysts. Gastrointest Endosc (2012) 1.26
Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol (2009) 1.24
Gastroparesis: current diagnostic challenges and management considerations. World J Gastroenterol (2009) 1.16
Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J Gastroenterol (2007) 1.15
Endoscopic management of biliary strictures after liver transplantation. World J Gastroenterol (2009) 1.11
Endoscopic ultrasound-guided biliary drainage. World J Gastroenterol (2012) 1.10
Eosinophilic esophagitis. World J Gastroenterol (2009) 1.09
Adverse events with non-anesthesiologist administration of propofol: what you see is what you get but getting (the right standard monitors) is how you see. Endoscopy (2016) 1.07
Intraductal biliary and pancreatic endoscopy: an expanding scope of possibility. World J Gastroenterol (2008) 1.03
Pain management in chronic pancreatitis. World J Gastroenterol (2008) 1.00
Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World J Gastroenterol (2009) 0.99
Diagnosis and management of ampullary adenoma: The expanding role of endoscopy. World J Gastrointest Endosc (2011) 0.98
Uncommon and rarely reported adverse events of endoscopic retrograde cholangiopancreatography. Dig Endosc (2013) 0.96
The utility of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. Gastroenterol Res Pract (2010) 0.96
Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas. Pancreas (2002) 0.95
Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding. Gastrointest Endosc (2012) 0.94
The practice of evidence-based medicine (EBM) in gastroenterology: discrepancies between EBM familiarity and EBM competency. Therap Adv Gastroenterol (2011) 0.94
Air embolism complicating gastrointestinal endoscopy: A systematic review. World J Gastrointest Endosc (2013) 0.94
Training in endoscopic submucosal dissection. World J Gastrointest Endosc (2013) 0.93
Hepatotoxic effects of therapies for tuberculosis. Nat Rev Gastroenterol Hepatol (2010) 0.92
Evaluation and management of patients with refractory ascites. World J Gastroenterol (2009) 0.89
Cystic neoplasms of the pancreas: a diagnostic challenge. World J Gastroenterol (2009) 0.89
Pancreatic stent placement is associated with resolution of refractory grade C pancreatic fistula after left-sided pancreatectomy. Am Surg (2009) 0.87
Boceprevir for chronic HCV genotype 1 infection. N Engl J Med (2011) 0.87
Diagnostic evaluation of pancreatic cystic malignancies. Surg Clin North Am (2010) 0.86
ERCP wire systems: the long and the short of it. World J Gastroenterol (2009) 0.86
Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol (2008) 0.85
Diagnostic yield of spiral enteroscopy when performed for the evaluation of abnormal capsule endoscopy findings. J Clin Gastroenterol (2011) 0.84
Efficacy and safety of a fully covered esophageal stent: a prospective study. Gastrointest Endosc (2012) 0.81
Prospective evaluation of spiral overtube-assisted ERCP in patients with surgically altered anatomy. Gastrointest Endosc (2012) 0.81
Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP). Inflamm Allergy Drug Targets (2009) 0.80
Algorithm for the management of endoscopic perforations: a quality improvement project. Am J Gastroenterol (2011) 0.79
Spiral enteroscopy is safe and effective for an elderly United States population of patients with numerous comorbidities. Clin Gastroenterol Hepatol (2010) 0.79
Choledochoduodenal fistula after biliary metallic stent placement for pancreatic cancer. Dig Endosc (2013) 0.78
Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography. World J Gastroenterol (2007) 0.78
Effectiveness and safety of endoscopic treatment of benign biliary strictures using a new fully covered self expandable metal stent. Diagn Ther Endosc (2013) 0.78
The role of Endoscopic Ultrasound (EUS) in the management of patients with pancreatic cancer: now bigger than ever. J Gastrointest Oncol (2013) 0.78
Predictors of malignancy in patients with suspicious or indeterminate cytology on pancreatic endoscopic ultrasound-guided fine-needle aspiration: a multivariate model. Pancreas (2014) 0.78
Computed tomography features of acinar cell carcinoma of the pancreas. Abdom Imaging (2013) 0.77
Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet? World J Gastroenterol (2012) 0.77
Endoscopic therapy for chronic pancreatitis: technical success, clinical outcomes, and complications. Curr Gastroenterol Rep (2009) 0.76
Therapeutic endoscopic retrograde cholangiopancreatography and instrumentation. Gastrointest Endosc Clin N Am (2012) 0.76
Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patients. Gastrointest Endosc (2011) 0.76
Intraobserver agreement among endosonographers for endoscopic ultrasound features of chronic pancreatitis: a blinded multicenter study. Pancreas (2011) 0.76
The lactulose breath test (LBT): modified, but still a lot of hot air? J Clin Gastroenterol (2008) 0.75
Performance characteristics of a new flexible nitinol 19-gauge endoscopic ultrasound-guided fine needle aspiration needle. Gut Liver (2013) 0.75
Post-endoscopic retrograde cholangiopancreatography uvular necrosis. Clin Gastroenterol Hepatol (2009) 0.75